Jump to content

Clofenciclan

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Boghog (talk | contribs) at 07:17, 21 September 2019 (capitalization of name). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Not to be confused with Clofenamide.
Clofenciclan
Clinical data
Routes of
administration		Oral
ATC code
  • none
Identifiers
  • 2-[1-(4-chlorophenyl)cyclohexyl]oxy-N,N-diethylethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H28ClNO
Molar mass309.874 g·mol−1
3D model (JSmol)
  • ClC1=CC=C(C2(CCCCC2)OCCN(CC)CC)C=C1
  • InChI=1S/C18H28ClNO/c1-3-20(4-2)14-15-21-18(12-6-5-7-13-18)16-8-10-17(19)11-9-16/h8-11H,3-7,12-15H2,1-2H3 checkY
  • Key:FFCARBNHUSWRGK-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Clofenciclan (Chlorphencyclan; Tonquil, Vesitan) is a dopamine-releasing agent developed by Boehringer & Soehne in the 1950s.[1] It proved unpopular as a treatment because of its pronounced stimulant activity.[2]

References

  1. ^ U.S. patent 3,254,083
  2. ^ Poeldinger W (January 1962). "[Therapeutic experiences with thiopropazate and with a combination of thiopropazate and chlorphencyclan (Vesitan) in psychiatry]". Praxis (in German). 51: 73–8. PMID 14487367.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Clofenciclan&oldid=916902579"